People with type 2 diabetes live longer, and there are new studies suggesting that health management strategies developed over the last few decades may be working.
A global survey of 16 high-income countries, led by researchers at the Baker Heart and Diabetes Institute, showed that: Mortality The number of people with type 2 diabetes is declining. The largest declines were seen in Asian jurisdictions such as Hong Kong, South Korea, Taiwan and Singapore.
Research published in Lancet Diabetes and EndocrinologyAlso showed that about half of the assessed jurisdictions, such as Singapore, the United States, Canada, Denmark and Hong Kong, have narrowed the difference in life expectancy between diabetics and diabetics.
The study investigated the deaths of 21 million people diagnosed with diabetes in 16 high-income countries between 1995 and 2016.
Professor Dianna Magliano OAM, lead author of the Baker Institute, and Professor Jonathan Shaw, deputy director of Clinical and Population Health, said the findings suggest that diabetes treatment continues to improve over time, at least in typical high-income countries. .. In this study.
The survey results are as follows. Global research published last yearHe also showed that the annual incidence of new cases diagnosed with type 2 diabetes (incidence of diabetes), led by Professors Magliano and Shaw, is stable or declining in many. High-income countries..
Professor Magliano said both findings were the reason for cautious optimism, but said that further improvement in life expectancy requires continuous improvement in diabetes prevention and management.
“Mortality is an important indicator of access to quality health care. Our findings suggest that we may be beginning to benefit from better education and disease management programs,” she said. Said.
“Population-level health promotion for smoking cessation and lifestyle changes has certainly led to lower levels of some risk factors, including smoking. High blood pressure And cholesterol.
“In addition, the use of blood pressure and cholesterol-lowering drugs to prevent cardiovascular disease in diabetic patients has increased over the past few decades, as cardiovascular disease is a major cause of death in patients with type 2 diabetes. Is important.
“There have also been significant advances in medical intervention and care for individuals suffering from acute cardiovascular events such as heart attacks and strokes.”
Professor Shaw said: “There is still a long way to go to manage many of the risks involved. DiabetesHowever, these findings provide promising evidence that we are heading in the right direction. “
This study includes data sources from Australia, Canada, Denmark, Hong Kong, Hungary, Israel, Italy (Lombardia), Latvia, Lithuania, Norway, Scotland, Singapore, South Korea, Spain (Catalonia), Taiwan, and the United States. increase.
Trends in All-Cause Mortality in People Diagnosed with Diabetes in High Income Environments: Multilateral Analysis of Aggregate Data, Lancet Diabetes and Endocrinology, DOI: 10.1016 / S2213-8587 (21) 00237-2, www.thelancet.com/journals/lan… (21) 00237-2 / fulltext
Provided by Baker Heart and Diabetes Institute
Quote: Mortality rates for people with type 2 diabetes are declining in many countries, including Australia, Canada and the United States (January 10, 2022). Obtained January 10, 2022 from https: //medicalxpress.com/news/2022-01-death-people-Diabetes-declined-countries.html
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.
Death rates among people with type 2 diabetes have declined in many countries including Australia, Canada and the US Source link Death rates among people with type 2 diabetes have declined in many countries including Australia, Canada and the US
The post Death rates among people with type 2 diabetes have declined in many countries including Australia, Canada and the US appeared first on California News Times.